Centre Hospitalier Intercommunal de Créteil, 94 000 Créteil, France.
Faculty of Medicine, University Paris-Est Créteil (UPEC), 94 000 Créteil, France.
Medicina (Kaunas). 2022 Nov 17;58(11):1662. doi: 10.3390/medicina58111662.
: The purpose of this study is to describe the effects of photobiomodulation on drusen regression with patients presenting with reticular pseudodrusen (RPD). : This study is a retrospective observational case series study including patients presenting with RPD who underwent treatment by photobiomodulation. All patients underwent a complete ophthalmic examination and multimodal imaging prior to treatment, including spectral-domain optical coherence tomography (SD-OCT). Eyes were treated two times per week for six consecutive weeks. Best corrected-visual acuity (BVCA) was measured prior and after treatment for all patients. The number of RPD on the SD-OCT scans centered on the macula and stages of RPD was noted at baseline and 6 months after the first treatment session. : Five eyes of five patients were included in the study. Mean BCVA did not change 6 months after treatment compared to baseline. Mean number of RPD per eye was 112.60 +/- 48.33 RPD at baseline and 111.6 +/- 49.29 in the same area 6 months after treatment. Changes in RPD distribution according to RPD classification were observed before and after treatment with photobiomodulation. Changes in distribution mostly concerned stages 1 and 3 RPD: Total number of stage 1 RPD was 289 and increased to 324 after treatment. Total number of stage 3 RPD was 97 at baseline and decreased to 67 6 months after treatment. Percentage of stage 1 RPD increased from 46% to 56% after treatment. Percentage of stage 3 RPD decreased from 20% to 13% after treatment. : Changes in RPD distribution were observed before and after treatment with photobiomodulation. The number of stage 3 reticular pseudodrusen decreased while number of stage 1 reticular pseudodrusen increased after treatment.
: 本研究旨在描述光生物调节对伴有网状假性脉络膜(RPD)的玻璃膜疣消退的影响。 : 这是一项回顾性观察性病例系列研究,纳入了接受光生物调节治疗的 RPD 患者。所有患者在治疗前均接受了全面的眼科检查和多模态成像,包括频域光相干断层扫描(SD-OCT)。每周治疗两次,共连续治疗 6 周。所有患者在治疗前后均进行最佳矫正视力(BCVA)测量。在基线和首次治疗后 6 个月,在黄斑中心的 SD-OCT 扫描上记录 RPD 的数量和 RPD 的分期。 : 本研究纳入了 5 名患者的 5 只眼。与基线相比,治疗后 6 个月 BCVA 无变化。治疗前每只眼的平均 RPD 数量为 112.60±48.33 个,治疗后 6 个月同一区域的平均 RPD 数量为 111.6±49.29 个。治疗前后 RPD 分布根据 RPD 分类的变化。治疗前后 RPD 分布的变化主要涉及 1 期和 3 期 RPD:1 期 RPD 的总数为 289 个,治疗后增加到 324 个。3 期 RPD 的总数为 97 个,治疗后减少到 67 个。治疗后 1 期 RPD 的比例从 46%增加到 56%。治疗后 3 期 RPD 的比例从 20%下降到 13%。 : 光生物调节治疗前后 RPD 分布发生变化。治疗后 3 期网状假性脉络膜的数量减少,而 1 期网状假性脉络膜的数量增加。